PET-CT for radiotherapy treatment planning and response monitoring in solid tumors
J. Bussink, J. Kaanders, W. van der Graaf and W. OyenArticles
NATREVCLIONC
2011
233--242
Imaging of therapy response in oncology
A. Chiti and W. OyenArticles
QJNUCMEDMOLIMA
2011
587--588
Titin based viscosity in ventricular physiology: an integrative investigation of PEVK-actin interactions
C. Chung, M. Methawasin, O. Nelson, M. Radke, C. Hidalgo, M. Gotthardt and H. GranzierArticles
JMOLCELCAR
2011
428--434
Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient mice
E. Vegt, M. Melis, A. Eek, M. de Visser, M. Brom, W. Oyen, M. Gotthardt, M. de Jong and O. BoermanArticles
EJNMMI
2011
623--632
Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients
I. Desar, J. Jacobs, C. Hulsbergen-vandeKaa, W. Oyen, P. Mulders, W. van der Graaf, G. Adema, C. van Herpen and I. de VriesArticles
IJC
2011
507--512
PET imaging of $alpha$v$beta$₃ integrin expression in tumours with �?��?�Ga-labelled mono-, di- and tetrameric RGD peptides
I. Dijkgraaf, C. Yim, G. Franssen, R. Schuit, G. Luurtsema, S. Liu, W. Oyen and O. BoermanArticles
EJNMMI
2011
128--137
2011
Comparative biodistribution of 12 textsuperscript1textsuperscript1textsuperscript1In-labelled gastrin/CCK2 receptor-targeting peptides
P. Laverman, L. Joosten, A. Eek, S. Roosenburg, P. Peitl, T. Maina, H. Mäcke, L. Aloj, E. von Guggenberg, J. Sosabowski, M. de Jong, J. Reubi, W. Oyen and O. BoermanArticles
EJNMMI
2011
1410--1416
Shortened dynamic (18)F-FDG PET
J. Disselhorst, D. Vriens, L. de Geus-Oei, W. Oyen and E. VisserArticles
JNM
2011
1330; author reply 1330--1330; author reply 1331
Cost-effectiveness of routine (18)F-FDG PET/CT in high-risk patients with gram-positive bacteremia
F. Vos, C. Bleeker-Rovers, B. Kullberg, E. Adang and W. OyenArticles
JNM
2011
1673--1678
Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients
W. Lesterhuis, I. de Vries, G. Schreibelt, A. Lambeck, E. Aarntzen, J. Jacobs, N. Scharenborg, M. van de Rakt, A. de Boer, S. Croockewit, M. van Rossum, R. Mus, W. Oyen, O. Boerman, S. Lucas, G. Adema, C. Punt and C. FigdorArticles
CLINCR
2011
5725--5735
Endocarditis: effects of routine echocardiography during Gram-positive bacteraemia
F. Vos, C. Bleeker-Rovers, P. Sturm, P. Krabbe, A. van Dijk, W. Oyen and B. KullbergArticles
NETHJM
2011
335--340
Modelling and simulation of [18F]fluoromisonidazole dynamics based on histology-derived microvessel maps
D. Mönnich, E. Troost, J. Kaanders, W. Oyen, M. Alber and D. ThorwarthArticles
PMB
2011
2045--2057
Vascular and metabolic response to bevacizumab-containing regimens in two patients with colorectal liver metastases measured by dynamic contrast-enhanced MRI and dynamic 18F-FDG-PET
D. Vriens, L. de Geus-Oei, A. Heerschap, H. van Laarhoven and W. OyenArticles
CLINCC
2011
E1--E5
Cochlear reimplantation with same device: surgical and audiologic results
K. van der Marel, J. Briaire, B. Verbist, R. Joemai, P. Boermans, F. Peek and J. FrijnsArticles
Laryngoscope
2011
1517--1524
The role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature
D. Vriens, J. de Wilt, G. van der Wilt, R. Netea-Maier, W. Oyen and L. de Geus-OeiArticles
Cancer
2011
4582--4594
Predicting IGF-1R therapy response in bone sarcomas: immuno-SPECT imaging with radiolabeled R1507
E. Fleuren, Y. Versleijen-Jonkers, A. van de Luijtgaarden, J. Molkenboer-Kuenen, S. Heskamp, M. Roeffen, H. van Laarhoven, P. Houghton, W. Oyen, O. Boerman and W. van der GraafArticles
CLINCR
2011
7693--7703
Angiotensin II type 1 receptor blockade does not enhance apoptotic cell death during ischemia and reperfusion in humans in vivo
P. Meijer, C. Wouters, W. Oyen, O. Boerman, G. Scheffer, P. Smits and G. RongenArticles
JCVPHA
2011
702--706
Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice
L. Gainkam, V. Caveliers, N. Devoogdt, C. Vanhove, C. Xavier, O. Boerman, S. Muyldermans, A. Bossuyt and T. LahoutteArticles
CONMMI
2011
85--92